DaVita Inc. (BVMF:DVAI34)

Market Cap	61.38B -1.1%
Revenue (ttm)	72.17B +6.7%
Net Income	4.08B -9.1%
EPS	56.03 +6.2%
Shares Out	n/a
PE Ratio	15.06
Forward PE	12.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Average Volume	10
Open	755.36
Previous Close	773.40
Day's Range	755.36 - 777.69
52-Week Range	546.63 - 835.50
Beta	0.92
RSI	55.12
Earnings Date	May 5, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 78,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DVAI34

Financial Performance

In 2025, DaVita's revenue was $13.64 billion, an increase of 6.46% compared to the previous year's $12.82 billion. Earnings were $746.80 million, a decrease of -20.24%.

Financial numbers in USD